Porvair Sciences has announced the addition of the novel Chromatrap chromatin immunoprecipitation (ChIP) assay range to its portfolio of products for epigenetics. Developed in conjunction with Department of Life Sciences at University of Swansea, UK – Chromatrap® uses a solid phase porous polymer functionalised with protein A, allowing the chromatin capture to be more efficient […]
NORTH BRUNSWICK, N.J.,– Hurel Corporation (“Hurel”) today announced that the results of toxicological evaluations performed on HurelStaticDog™, Hurel’s new, patent-pending method of culturing actual liver cells from the canine (dog) species, will be highlighted as a part of UCB’s keynote overview of the current state of the art of in vitro models to use in […]
ALAMEDA, Calif. — LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that it is now offering 100 selected ProSpec-Tany TechnoGene (ProSpec) manufactured recombinant proteins related to stem cell research in its recently launched LifeMap BioReagents™ portal (https://bioreagents.lifemapsc.com) to researchers worldwide. ProSpec’s innovative recombinant proteins, including growth factors, signaling molecules, differentiation […]
SANTA CLARA, Calif. — Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. The Company expects to report cash-on-hand of at least $38 million as of March 31, 2013. […]
GILBERTSVILLE, Pa.– Rockland Immunochemicals, Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, today announced the acquisition of the Epi-Plus® antibody product line from 21st Century Biochemicals, Inc. Epi-Plus® antibodies are widely regarded as the most well validated antibodies available for epigenetics research. All Epi-Plus® […]
Paris (France)- CanCELL™ cell lines are featuring gene knock-outs of the major cancer relevant oncogenes and tumor suppressor genes. This new product line answers identified market needs in oncology research and drug discovery. CanCELL™ cell lines were generated by applying Cellectis bioresearch proprietary TALEN™ technology on the most commonly used cell lines for colorectal and […]
ChromoTek GmbH (Munich, Germany) has developed a series of highly sensitive protein-protein-interaction (PPI) assays to screen compounds that resolve the binding of two proteins within cells. The so-called fluorescent two hybrid (F2H®) technology is based on a proprietary cell line that contains a spot-like landing platform where one interaction partner binds. The interacting proteins are […]
MADISON, WIS., – Cellular Dynamics International (CDI) today announced that the company is opening a facility in Novato, Calif, leasing space from the Buck Institute for Research on Aging. This opening of a second CDI facility is in response to the company receiving a $16 million grant award from the California Institute of Regenerative Medicine […]
Madison, WI,– Mirus Bio has expanded its transfection expertise with the development of the TransIT-BrCa Transfection Reagent -a high performance, low toxicity, DNA transfection reagent specifically formulated for breast cancer cell types. This new reagent offers users: • Superior DNA Delivery—Achieve high expression levels in breast cancer cell types including: MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, T47D. […]
Porvair Sciences has announced the addition of the novel Chromatrap chromatin immunoprecipitation (ChIP) assay range to its portfolio of products for epigenetics. Developed in conjunction with Department of Life Sciences at University of Swansea, UK – Chromatrap® uses a solid phase porous polymer functionalised with protein A, allowing the chromatin capture to be more efficient […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
